Intracellular Trafficking of AAV5 Vectors

被引：1
|
作者：
Balakrishnan, Balaji [1 ,2 ]
Jayandharan, Giridhara R. [1 ,2 ]
机构：
[1] Christian Med Coll & Hosp, Dept Hematol, Vellore 632004, Tamil Nadu, India
[2] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India
来源：
HUMAN GENE THERAPY METHODS | 2016年 / 27卷 / 02期
关键词：
ADENOASSOCIATED VIRUS; PATHWAY;
D O I：
10.1089/hgtb.2016.020
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The present study was designed to visualize the cellular trafficking of adeno-associated virus (AAV) vectors in general and AAV5 serotype vectors in particular. We fluorescently labeled AAV5 wild-type and a mutant (S652A) virus and studied their infection process by live cell imaging and confocal microscopy. Our data demonstrate considerable difference in the ability of these vectors to reach the nuclear compartment within the first 6 hr after infection.
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [41] Directed Evolution of AAV1, AAV5 and AAV9 Variants for Efficient Gene Delivery to Eye
    Pendse, Nachiket
    Magdaleno, Eduardo
    Luna, Fabio
    Ge, Tan
    Hintzen, Steph
    Hill, Jake
    Mcelroy, Cameron
    Chen, Jayson
    Tam, Lawrence
    Hudry, Eloise
    Booler, Helen
    Stoner, Kirsten
    Penraat, Kelley
    Hedgeland, Mark
    Babaria, Shraddha
    Walker, John
    Ellis, Scott
    Ozsolak, Fatih
    MOLECULAR THERAPY, 2024, 32 (04) : 479 - 479
  • [42] Quantitative Imaging Comparison of Intracellular Trafficking of AAV Capsid Variants
    Basner-Tschakarjan, Etiena
    Hinderer, Christian J.
    Cheng, Xin
    Gadue, Paul
    Mingozzi, Federico
    High, Katherine A.
    MOLECULAR THERAPY, 2012, 20 : S100 - S100
  • [43] Characterizing a Novel Antibody Epitope on the AAV5 Capsid at Atomic Resolution for the Creation of Host Antibody Resistant Recombinant Gene Delivery Vectors
    Jose, Ariana
    Mietzsch, Mario
    Smith, Kennon
    Kurian, Justin
    Chipman, Paul
    McKenna, Robert
    Chiorini, John
    Agbandje-McKenna, Mavis
    MOLECULAR THERAPY, 2018, 26 (05) : 179 - 180
  • [44] OneBac 2.0: Sf9 Cell Lines for Production of AAV5 Vectors with Enhanced Infectivity and Minimal Encapsidation of Foreign DNA
    Mietzsch, Mario
    Casteleyn, Vincent
    Weger, Stefan
    Zolotukhin, Sergei
    Heilbronn, Regine
    HUMAN GENE THERAPY, 2015, 26 (10) : 688 - 697
  • [45] Intracellular trafficking of adeno-associated viral vectors
    W Ding
    L Zhang
    Z Yan
    J F Engelhardt
    Gene Therapy, 2005, 12 : 873 - 880
  • [46] Insights on the intracellular trafficking of PDMAEMA gene therapy vectors
    Bitoque, Diogo B.
    Rosa da Costa, Ana M.
    Silva, Gabriela A.
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2018, 93 : 277 - 288
  • [47] Nanobodies inserted into different surface loops retarget AAV5 and AAV9 to specific cells
    Schaefer, W.
    Richter, N.
    Jargalsaikhan, S.
    Haag, F.
    Braren, I.
    Thirion, C.
    Adriouch, S.
    Koch-Nolte, F.
    Mann, A. M.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A68 - A68
  • [48] Intracellular trafficking of adeno-associated viral vectors
    Ding, W
    Zhang, L
    Yan, Z
    Engelhardt, JF
    GENE THERAPY, 2005, 12 (11) : 873 - 880
  • [49] Chemical vectors for gene delivery: uptake and intracellular trafficking
    Pichon, Chantal
    Billiet, Ludivine
    Midoux, Patrick
    CURRENT OPINION IN BIOTECHNOLOGY, 2010, 21 (05) : 640 - 645
  • [50] Brain organoids as a platform to study subcellular trafficking of recombinant AAV vectors
    Leysen, M.
    Salmon, I.
    Sutter, S. O.
    Fraefel, C.
    Ranga, A.
    Moeyaert, B.
    Henkaerts, E.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A141 - A141
12345